Evidence map›Paper›PMID 25828248›Full record

ArticleThe Journal of infectious diseases2015

18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters.

Mark N Polizzotto, Corina Millo, Thomas S Uldrick, Karen Aleman, Millie Whatley, Kathleen M Wyvill, Deirdre O'Mahony, Vickie Marshall, Denise Whitby, Roberto Maass-Moreno and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Cancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Oncologic Treatment of HIV-Associated Kaposi Sarcoma 40 Years on.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022
    Review
  11. Castleman disease.Nature reviews. Disease primers · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Mark N PolizzottoHIV and AIDS Malignancy Branch.
Corina MilloPositron Emission Tomography Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda.
Thomas S UldrickHIV and AIDS Malignancy Branch.
Karen AlemanHIV and AIDS Malignancy Branch.
Millie WhatleyPositron Emission Tomography Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda.
Kathleen M WyvillHIV and AIDS Malignancy Branch.
Deirdre O'MahonyHIV and AIDS Malignancy Branch.
Vickie MarshallViral Oncology Section, AIDS and Cancer Virus Program, Frederick National Cancer Laboratory for Cancer Research, Maryland.
Denise WhitbyViral Oncology Section, AIDS and Cancer Virus Program, Frederick National Cancer Laboratory for Cancer Research, Maryland.
Roberto Maass-MorenoPositron Emission Tomography Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda.
Seth M SteinbergBiostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute.
Richard F LittleHIV and AIDS Malignancy Branch.
Robert YarchoanHIV and AIDS Malignancy Branch.
AIDS United · USNational Institutes of Health · USFrederick National Laboratory for Cancer Research · USCancer Institute (WIA) · IN

Funding

Clinical Trials of Patients with AIDS-Related MalignanciesZIABC010888 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI YARCHOAN, ROBERT · 2009 to 2025
$20.6M
Patient Oriented Research in Viral Malignancies and HIV-associated CancersZIABC011700 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI YARCHOAN, ROBERT · 2016 to 2017
$1.2M
Pathogenesis and therapy of KSHV-associated MalignanciesZIABC011500 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI POLIZZOTTO, MARK · 2013 to 2015
$669k
CCR NIH HHS HHSN261200800001CIntramural NIH HHSNCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

backgroundKaposi sarcoma herpesvirus (KSHV)-associated multicentric Castleman disease (MCD) is a lymphoproliferative inflammatory disorder commonly associated with human immunodeficiency virus (HIV). Its presentation may be difficult to distinguish from HIV and its complications, including lymphoma. Novel imaging strategies could address these problems.

methodsWe prospectively characterized (18)F-fluorodeoxyglucose positron emission tomography (PET) findings in 27 patients with KSHV-MCD. Patients were imaged with disease activity and at remission with scans evaluated blind to clinical status. Symptoms, C-reactive protein level, and HIV and KSHV loads were assessed in relation to imaging findings.

resultsKSHV-MCD activity was associated with hypermetabolic symmetric lymphadenopathy (median maximal standardized uptake value [SUVmax], 6.0; range, 2.0-8.0) and splenomegaly (3.4; 1.2-11.0), with increased metabolism also noted in the marrow (2.1; range, 1.0-3.5) and salivary glands (3.0; range, 2.0-6.0). The (18)F-fluorodeoxyglucose PET abnormalities improved at remission, with significant SUVmax decreases in the lymph nodes (P = .004), spleen (P = .008), marrow (P = .004), and salivary glands (P = .004). Nodal SUVmax correlated with symptom severity (P = .005), C-reactive protein level (R = 0.62; P = .004), and KSHV load (R = 0.54; P = .02) but not HIV load (P = .52).

conclusionsKSHV-MCD activity is associated with (18)F-FDG PET abnormalities of the lymph nodes, spleen, marrow, and salivary glands. These findings have clinical implications for the diagnosis and monitoring of KSHV-MCD and shed light on its pathobiologic mechanism.

Indexed as

AdultCastleman DiseaseC-Reactive ProteinFemaleFluorine RadioisotopesFluorodeoxyglucose F18Herpesvirus 8, HumanHIV InfectionsHumansLymph NodesMaleMiddle AgedPositron-Emission TomographyProspective StudiesSalivary GlandsSarcoma, KaposiC-Reactive ProteinFluorine RadioisotopesFluorodeoxyglucose F1818F-FDG positron emission tomographyCastleman diseaseHIVhuman herpesvirus 8 (HHV-8)/Kaposi sarcoma herpesvirus (KSHV)

Identifiers

PMID25828248
PMCPMC4577043
OpenAlexW1956542573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.